We are live on ! Find out more
LEGN icon

Legend Biotech
LEGN

139 hedge funds and large institutions have $2.33B invested in Legend Biotech in 2021 Q4 according to their latest regulatory filings, with 66 funds opening new positions, 44 increasing their positions, 23 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

371% more first-time investments, than exits

New positions opened: 66 | Existing positions closed: 14

91% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 23

58% more funds holding

Funds holding: 88 → 139 (+51)

18% more capital invested

Capital invested by funds: $1.97B → $2.33B (+$357M)

2.95% more ownership

Funds ownership: 13.48% → 16.43% (+2.9%)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

53% less call options, than puts

Call options by funds: $2.89M | Put options by funds: $6.1M

Holders
139
Holders Change
+51
Holders Change %
+57.95%
% of All Funds
2.14%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
66
Increased
44
Reduced
23
Closed
14
Calls
$2.89M
Puts
$6.1M
Net Calls
-$3.21M
Net Calls Change
-$3.6M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$85.4M
2
BlackRock
BlackRock
New York
+$79.6M
3
Artisan Partners
Artisan Partners
Wisconsin
+$40.6M
4
HA
HHLR Advisors
Cayman Islands
+$38M
5
State Street
State Street
Massachusetts
+$27.5M

Top Sellers

Rank Fund Capital Flow
1
MICM
Matthews International Capital Management
California
-$17.8M
2
VC
Vivo Capital
California
-$12.4M
3
APM
Avidity Partners Management
Texas
-$9.24M
4
AA
ALPS Advisors
Colorado
-$8.96M
5
Citadel Advisors
Citadel Advisors
Florida
-$7.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
ADL
126
Asset Dedication LLC
California
$36K – – –
TRCT
127
Tower Research Capital (TRC)
New York
$36K +$24.9K +490 +168%
CI Investments Inc
128
CI Investments Inc
Ontario, Canada
$36K +$38.9K +766 New
GWS
129
Glassman Wealth Services
Virginia
$20K +$21.3K +420 New
PNC Financial Services Group
130
PNC Financial Services Group
Pennsylvania
$15K +$15.8K +311 New
UB
131
UMB Bank
Missouri
$15K +$16.8K +331 New
Manulife (Manufacturers Life Insurance)
132
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$12K -$4.03M -79,500 -24%
QCG
133
Quadrant Capital Group
Ohio
$10K -$3.35K -66 -24%
S
134
SignatureFD
Georgia
$7K – – –
SOW
135
State of Wyoming
Wyoming
$6K +$1.62K +32 +34%
BIA
136
Bell Investment Advisors
California
$5K -$4.77K -94 -48%
US Bancorp
137
US Bancorp
Minnesota
$4K -$12.7K -250 -75%
QT
138
Quantbot Technologies
New York
$4K +$5.07K +100 New
AA
139
ALPS Advisors
Colorado
– -$8.96M -177,274 Closed
SSA
140
Schonfeld Strategic Advisors
New York
– -$2.8M -55,303 Closed
JF
141
Jump Financial
Illinois
– -$2.08M -41,116 Closed
SCF
142
Sante Capital Fund
Texas
– -$1.85M -36,617 Closed
ECM
143
ExodusPoint Capital Management
New York
– -$1.72M -33,932 Closed
E
144
Ergoteles
New York
– -$809K -16,008 Closed
PAMI
145
Perseverance Asset Management International
Cayman Islands
– -$391K -7,743 Closed
GCP
146
GSA Capital Partners
United Kingdom
– -$309K -6,104 Closed
Simplex Trading
147
Simplex Trading
Illinois
– -$102K -2,003 Closed
CMBA
148
C.M. Bidwell & Associates
Hawaii
– -$56K -1,110 Closed
PCM
149
Penserra Capital Management
California
– -$36K -720 Closed
GAM
150
Gemmer Asset Management
California
– -$5K -100 Closed
3 4 5
6
7

LEGN Hedge Fund Activity: Q4 2021 in Review

139 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Legend Biotech (LEGN) for Q4 2021, worth a combined $2.33B — up 18% from $1.97B a quarter earlier.

Buyers outnumbered sellers: 66 funds opened new LEGN positions and 14 closed out — a net gain of 52 holders — while 44 added to existing stakes and 23 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $85.4M. The largest seller was Matthews International Capital Management, cutting an estimated $17.8M.

  • 139 institutional investors held Legend Biotech (LEGN) as of Q4 2021, up from 88 in Q3 2021.
  • Funds reported $2.33B of Legend Biotech stock for Q4 2021, up 18% quarter-over-quarter.
  • 66 funds opened new Legend Biotech positions in Q4 2021 and 14 closed out, a net change of +52 holders.
  • The largest Legend Biotech buyer in Q4 2021 was Wellington Management Group, an estimated $85.4M added.
  • The largest Legend Biotech seller in Q4 2021 was Matthews International Capital Management, an estimated $17.8M sold.

Based on aggregated 13F filings for Q4 2021.